<html>
<head>PUBMED IDs for AKR7A3</head>
<body bgcolor='#C5F0F2'><h1>AKR7A3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10383892/'>cDNA cloning, expression and activity of a second human aflatoxin B1-metabolizing member of the aldo-keto reductase superfamily, AKR7A3.</a> June 29  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/18416522/'>Protection against aflatoxin B1-induced cytotoxicity by expression of the cloned aflatoxin B1-aldehyde reductases rat AKR7A1 and human AKR7A3.</a> April 18  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18416466/'>Analysis of the human Atox 1 homologue in Wilson patients.</a> April 18  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18416462/'>Effects of alpha-adrenoreceptor antagonists on apoptosis and proliferation of pancreatic cancer cells in vitro.</a> April 18  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18416461/'>Vascular endothelial growth factor attenuates hepatic sinusoidal capillarization in thioacetamide-induced cirrhotic rats.</a> April 18  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18416455/'>Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro.</a> April 18  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/25526449/'>The role of cytochromes p450 and aldo-keto reductases in prognosis of breast carcinoma patients.</a> March 18  2014<br></body></html>
